Status:
COMPLETED
iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide
Lead Sponsor:
Evidence-Based Practice Institute, Seattle, WA
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
University of Maryland
Conditions:
Child Behavior Disorders
Suicide and Self-harm
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
This study is a 16-week intent-to-treat randomized controlled trial (RCT) with 120 suicidal juvenile justice (JJ)-involved transition-age (TA) youth (age 15-21 years) and a primary caregiver (dyads). ...
Detailed Description
The goal of this 33-month Fast Track study is to significantly expand iKinnect, an efficacious paired mobile app that supports parents (in delivering) and youth (in receiving) evidence-based technique...
Eligibility Criteria
Inclusion
- PARENT/GUARDIAN INCLUSION CRITERIA:
- 18 years or older
- Fluent in English
- Owns an Android or iPhone-based smartphone with a data plan and is the primary user of the phone
- Primary caregiver and supervisor of a youth aged 15-21 on probation or receiving post-incarceration reentry services at time of screening
- YOUTH INCLUSION CRITERIA:
- Age 15-21 years
- Fluent in English
- Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan
- Currently resides in same household as linked parent/legal guardian at least 5 days per week
- Has been arrested at least once and is receiving community-based JJ services related to probation or re-entry
- At significant risk for suicide, as evidenced by one of the following: one or more lifetime suicide attempts; elevated past-month suicidal ideation (\>24 on the SIQ-JR99, or self-injury repetition (\>3 lifetime self-harm episodes, including one in the past 12 weeks before screening)
- Willing to disclose NSSI and suicidal behaviors to parent
- To ensure consistency of planned and actual enrollment, particularly of Black youth, researchers will begin to exclude youth of certain races once pre-established recruitment milestones for a specific racial group is achieved.
Exclusion
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04909203
Start Date
June 1 2023
End Date
October 21 2025
Last Update
December 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland, Baltimore
Baltimore, Maryland, United States, 21201
2
Evidence-Based Practice Institute
Seattle, Washington, United States, 98126